Sunday, June 4, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

NIAID Issues RFI for Biodefense Dry Vaccine Development

by Global Biodefense Staff
October 31, 2012

The National Institute of Allergy and Infectious Diseases (NIAID) has issued a Request for Information (RFI) seeking input from product developers on vaccine formulation technologies to develop dry vaccines against NIAID Category A, B and C priority pathogens. 

The primary focus of the RFI is to gather information for Biodefense vaccine development about available solid vaccine formulations that increase duration of stability, eliminate cold chain requirements and minimize the need for preservatives.

Of greatest interest are dry vaccine formulations that rapidly achieve protective efficacy in a single vaccination, although information on dry vaccine formulations that require multiple administrations to be effective may also be submitted. Dry vaccine formulations may contain adjuvants to achieve a rapid immune response.

Technologies may include but are not limited to lyophilization, spray drying, foam drying, nanoparticles and other emerging drying technologies.

Further details are available under Solicitation Number: RFI-NOT-AI-12-058. The response deadline is November 30, 2012.

Tags: NanotechRFIVaccines

Related Posts

Vials of finished vaccines
Funding News

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics
Industry News

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023
Medical Countermeasures

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Load More

Latest News

Vials of finished vaccines

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Biodefense Headlines – 25 April 2023

Biodefense Headlines – 25 April 2023

April 25, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2023 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2023 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy